Friday, February 28, 2025
spot_img

No. 4/2025 – Managers transactions

Nasdaq Copenhagen                                                                                   
Nikolaj Plads 6
DK-1067 Copenhagen K   

Copenhagen, 27 February 2025
ANNOUNCEMENT no.4/2025

Managers’ transactions

Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 27 February 2025.

Details of the person discharging managerial responsibilities/person closely associated  
Name: Joanna Lucyna Iwanowska-Nielsen
Reason for the notification:  
Position/status: Member of the board of directors in Cemat A/S
Initial notification/Amendment: Initial
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
Name: Cemat A/S
LEI: 213800899MWAZT9KQZ78

 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
Description of the financial instrument, type of instrument: Shares
Identification code: ISIN DK0010271584
Nature of the transaction: Purchase of shares
Price(s): DKK 1.00
Volume (s): 87,485
Aggregated information:  
  • Aggregated volume
87,485
  • Price
DKK 87,485, equivalent to DKK 1.00 per share
Date of the transaction: 25 February 2025
Place of the transaction: Nasdaq Copenhagen, XCSE
     

Cemat A/S

Jaroslaw Pawel Lipinski
CEO                      

This announcement has been prepared in a Danish-language and an English-language version. In case of doubt, the Danish version prevails.

Attachment

  • Announcement no. 4 – 27.02.2025 – Managers transactions

Powered by SlickText.com

Hot this week

Monument Reports Second Quarter Fiscal 2025 Results

Gross Revenue of US$19.80 Million and Cash Cost of...

CORRECTION – Global Net Lease Reports Fourth Quarter and Full Year 2024 Results

In a release issued under the same headline earlier...

Lendlease Global Commercial REIT Secures Approximately 13% Rental Increase for Jem Office

Demonstrated strength in the Singapore portfolio with good rental...

Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris

Cenerimod is a novel oral S1P1 receptor modulator with...

Topics

spot_img

Related Articles

Popular Categories

spot_img